PFS
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
PFS
May 18, 2024, 08:47 |
Blog
Elisa Agostinetto: At ESMO Breast24, Hope Rugo presents results of CAPItello-291
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on X/Twitter: ''At…
May 18, 2024, 04:17 |
Blog
Sara Tolaney: Interesting data from Mafalda Oliveira from SERENA-2 at ESMO Breast24
Sara Tolaney shared a post on X: ''Interesting data from Mafalda Oliveira from SERENA-2 demonstrating…
May 18, 2024, 04:13 |
Blog
Elisa Agostinetto: Is this a new predictive biomarker for PFS with camizestrant
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on X/Twitter: ''At…
May 16, 2024, 02:34 |
Blog
Dr. Domenica Lorusso discussed the survival analysis of the PAOLA1 trial - International Journal of Gynecological Cancer
International Journal of Gynecological Cancer shared on LinkedIn: "New episode of Weekly Podcast Dr. Domenica…
May 9, 2024, 00:16 |
Insight
Update CheckMate 9ER summarized by Sergio Cifuentes
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X: “Update CheckMate 9ER - PFS:…
Apr 22, 2024, 17:31 |
Blog
Angela Mastronuzzi: A trip to the vibrant Memphis for Posterior Fossa Society's global meeting!
Angela Mastronuzzi shared on LinkedIn: "A trip to the vibrant Memphis for Posterior Fossa Society's global…
Apr 8, 2024, 16:20 |
Drugs
Rami Manochakian: BIG NEWS press release by AstraZeneca!
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: “Hot Off…
Mar 14, 2024, 19:28 |
Drugs
François-Clément Bidard: A prospective study to document the efficacy of the combo Fulvestrant+Everolimus
Erika Hamilton, Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute, shared…
Feb 25, 2024, 14:57 |
Blog
Robert Francomano: Significant change in regulatory priorities by the FDA
Robert Francomano, Chief Commercial Officer at SELLAS, shared on LinkedIn: "The recent emphasis by the…
Dec 17, 2023, 16:45 |
Opinion
Manni Mohyuddin: Sad to see surrogacy word loosely used in a plenary session
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, recently…
1
2
All:
13
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube